Michael Quirmbach, CordenPharma CEO

Two in­vestors team up for Cor­den­Phar­ma buy­out fol­low­ing mR­NA vac­cine suc­cess

In March, Cor­den­Phar­ma was list­ed among the phar­ma gi­ants picked by the Ger­man gov­ern­ment as re­cip­i­ents of more than $3 bil­lion to en­sure that the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA